Astika (ASKH) Stock Price, News & Analysis

Company Overview

Astika (OTCMKTS:ASKH) is a vertically integrated medical cannabis company focused on the research, cultivation, extraction and distribution of cannabinoid-based products. Since its founding in 2016 by biotech entrepreneur María Castillo, the company has built a network of GMP-certified cultivation sites and extraction laboratories across Spain, Colombia and Uruguay. These facilities support a product portfolio that includes cannabinoid oils, capsules, tinctures, topical formulations and dermatological cosmetics, all manufactured under stringent quality-control standards.

Astika conducts extensive research and development in partnership with academic institutions in Europe and Latin America, with an emphasis on novel extraction techniques and bioavailability enhancements. The company has developed proprietary processes for isolating key phytocannabinoids such as cannabidiol (CBD), tetrahydrocannabinol (THC) and minor cannabinoids, enabling tailored formulations for pain management, neurological disorders and dermatological applications. Ongoing clinical collaborations aim to expand its pipeline into prescription-grade therapeutics.

Headquartered in Madrid, Spain, Astika maintains regional offices in Bogotá and Montevideo to oversee its cultivation operations and regulatory compliance in key Latin American markets. A dedicated commercialization team manages distribution agreements across the European Union, Latin America and select U.S. states with medical cannabis programs. Through strategic alliances with pharmaceutical and wellness distributors, Astika seeks to broaden patient access to its cannabinoid therapies and wellness products.

Under the leadership of CEO María Castillo and COO José Álvarez, Astika has prioritized scalability and regulatory alignment. The executive team includes Chief Scientific Officer Dr. Peter Johnson, who heads the company’s clinical research efforts, and Finance Director Ana López, responsible for capital budgeting and operational finance. Together, they are positioning Astika as a fully integrated player in the rapidly evolving medical cannabis industry.

Key Stats

• Today's Range: $0.0028 to $0.0028
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.03
• Volume: 13,000 shs
• Average Volume: 86,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ASKH Stock Analysis - Frequently Asked Questions

How have ASKH shares performed this year?

Astika's stock was trading at $0.0017 on January 1st, 2025. Since then, ASKH shares have increased by 64.7% and is now trading at $0.0028.

How do I buy shares of Astika?

Shares of ASKH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: Recreation
• Current Symbol: OTCMKTS:ASKH
• CIK: 1511161
• Web: N/A
• Phone: (649) 929-0502
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A